Data Platform
Sign InStart a Free Trial

HCPCS J9098 Fee Schedule

Last Updated: August 2025

Injection, cytarabine liposome, 10 mg
Login to see

Healthcare providers use this code to document and receive reimbursement for visits that address moderate-level medical decision-making, often including multiple diagnoses or prescription management.

Key FactDetail
Service Type

Chemotherapy Drugs

Common Place of Service

21 - Inpatient Hospital

22 - On Campus-Outpatient Hospital

Common Modifiers
Complexity LevelModerate

National average reimbursement for HCPCS J9098 by major payers:

bcbs

$280.68

uhc

$636.33

aetna

$625.33

cigna

$665.96


Find Fee Schedule & Reimbursement for Other Codes

Use our free lookup tool to explore fee schedules and reimbursement rates for any billing code. Select a code type, then type or select a code to view its details.


What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J9098. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the J9098 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules


Medicare & Medicaid Rates

Government-set reimbursement amounts


Private Insurance Rates

Negotiated rates between providers and insurance companies


Geographic Location

Costs may be higher in urban areas.


Provider Type

Hospital providers may have different rates than private practice.

HCPCS J9098 vs. Other Chemotherapy Drugs Codes

The HCPCS J9098 code is part of the Chemotherapy Drugs services . It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.

The HCPCS J9098 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.

HCPCS CodeComplexity LevelDescription
J9071Low
Injection, cyclophosphamide, (auromedics), 5 mg
J9098Moderate
Injection, cytarabine liposome, 10 mg
J9100Low
Injection, cytarabine, 100 mg

See what providers are getting paid in 2025 for J9098:

HCPCS J9098 Fee Schedule & Reimbursement Rates

The HCPCS J9098 fee schedule varies by payer type. Below are Medicare rates for 2025 and average in-network rates by state across major payers:

CodeMedicare RateAvg. BCBS National RateMore Info
J9071$1.32

Get a free sample report

J9098$280.68

Get a free sample report

J9100$0.82

Get a free sample report

Reimbursement rates depend on provider contracts, region, and payer. Always verify rates with your insurance provider or medical billing department.


What is price transparency?

The Price Transparency Rule is a federal law that took effect in July 2022, requiring all commercial payers to publicly disclose their prices through machine-readable files (MRFs). In short, this regulation mandates that insurance companies make healthcare costs transparent to the public.

Our data comes directly from these insurer-posted MRFs, ensuring compliance with the Price Transparency Rule. While PayerPrice is working toward a future where providers and payers collaborate for 100% upfront price certainty, it's important to acknowledge that data limitations and occasional errors may exist.


Unlock access to price transparency insights today.

First Name

Last Name

Email

Role / Title

Company

How did you hear about us?

PayerPrice needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.